Singlin 2 mg Tablet is a product of Renata PLC. It contains Repaglinide, a medicine used in type 2 diabetes to help control blood sugar levels alongside diet and exercise.
There are 15 brands of Repaglinide listed in Bangladesh. 4 of them have a lower unit price than Singlin. The lowest listed price is Singlin 1 mg Tablet at ৳ 3.00 per unit.
What is Singlin 2 mg Tablet?
Singlin 2 mg Tablet is manufactured by Renata PLC and contains Repaglinide, a meglitinide analogue. It is prescribed for adults with type 2 diabetes when diet and exercise alone do not adequately control blood sugar. Repaglinide works by stimulating the pancreas to release more insulin. It can be used alone or with metformin. The tablet is available in a pack of 5 x 10 tablets. Always follow your doctor's instructions regarding dose and timing, as these are individualized.
Uses of Singlin
Singlin 2 mg Tablet is used to lower blood glucose in adults with type 2 diabetes mellitus whose high blood sugar is not controlled by diet and exercise alone. It may also be prescribed in combination with metformin when blood sugar remains high despite treatment. This medicine is not for type 1 diabetes or diabetic ketoacidosis. Your doctor will determine if it is suitable for you.
How to use Singlin
Take Singlin 2 mg Tablet exactly as your doctor prescribes. The dose and how often you take it are decided by your doctor based on your blood sugar levels and other factors. It is usually taken before meals, but your doctor will give you specific instructions. Do not change the dose or stop taking it without consulting your doctor. If you miss a dose, ask your doctor or pharmacist what to do.
Side effects of Singlin
The most common side effect of Singlin 2 mg Tablet is low blood sugar (hypoglycemia), which can cause symptoms like shaking, sweating, and confusion. Other side effects may include upper respiratory infections, diarrhea, constipation, nausea, and vomiting. Allergic reactions such as rash and hives can occur. If you experience any side effects, contact your doctor or pharmacist for advice.
Safety and precautions
Singlin 2 mg Tablet can cause low blood sugar, especially if you skip meals or take it with certain other medicines. Tell your doctor about all medications you take, including over-the-counter products. It is not recommended for type 1 diabetes or diabetic ketoacidosis. Safety during pregnancy has not been established, and it may pass into breast milk. Consult your doctor before use if you are pregnant, planning pregnancy, or breastfeeding. During illness, surgery, or trauma, insulin may be needed instead; your doctor will advise. Store below 30°C, away from light and children.
Frequently asked questions
What is the price of Singlin 2 mg Tablet?
The listed price is ৳ 5.00. For the most current price, check the website or ask your pharmacist, as prices can vary.
What does the generic name Repaglinide mean?
Repaglinide is the generic name of the active ingredient in Singlin 2 mg Tablet. It belongs to a group of medicines called meglitinide analogues, which help lower blood sugar by increasing insulin release from the pancreas.
What is Singlin 2 mg Tablet used for and what kind of medicine is it?
Singlin 2 mg Tablet is used to treat type 2 diabetes in adults when diet and exercise alone do not control blood sugar. It is a meglitinide analogue, an oral blood glucose-lowering medicine that stimulates insulin secretion.
How should Singlin 2 mg Tablet be taken?
Take Singlin 2 mg Tablet exactly as your doctor prescribes. The dose and timing are decided by your doctor based on your needs. Do not adjust the dose yourself; ask your doctor or pharmacist for specific instructions.
Repaglinide is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with type 2 diabetes mellitus (NIDDM) whose hyperglycemia cannot be controlled satisfactorily by diet and exercise alone. It is also indicated for use in combination with Metformin to lower blood glucose ... Read moreRepaglinide is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with type 2 diabetes mellitus (NIDDM) whose hyperglycemia cannot be controlled satisfactorily by diet and exercise alone. It is also indicated for use in combination with Metformin to lower blood glucose in patients whose hyperglycemia cannot be controlled by exercise, diet, and either Repaglinide or Metformin alone.
Pharmacology
Repaglinide binds to specific receptors in the cell membrane leading to the closure of ATP dependent K+ channels and the depolarisation of cell membrane. This in turn, leads to Ca++ influx, increased intracellular Ca++ and the stimulation of insulin secretion.
Dosage & Administration
For patients not previously treated or whose HbA1c is <8%, the starting dose should be 0.5 mg before each meal.
For patients previously treated with blood glucose-lowering drugs and whose HbA1c is >8%, the initial dose is 1 or 2 mg before each meal.
Repaglinide should be taken immediately or up to 30 minutes before each meal.
Dosage should be adjusted according to response at intervals of 1-2 weeks; up to 4 mg may be given as a single-dose, maximum 16 mg daily.
Interaction
The dose of Repaglinide may need to be adjusted, if taken with other medications. The possible interactions of Repaglinide with other drugs are:
Inhibitors of the cytochrome P450 enzyme system (azole antifungals and macrolides) may lead to lower Repaglinide clearance and longer half life.
Inducers of the cytochrome P450 enzyme system (Rifampin, Phenobarbital, Carbamazepine, Troglitazone, etc.) may accelerate Repaglinide metabolism and shorten its effect.
Cimetidine has no significant effect on Repaglinide absorption or clearance.
Repaglinide has no significant effect on Digoxin, Theophyllin, or Warfarin.
Highly protein bound drugs (e.g., NSAIDs) may increase the plasma level of unbound Repaglinide and potentiate its glucose lowering effect. Thus, co-administration of these drugs with Repaglinide may increase the risk of hypoglycaemia.
The risk of hypoglycaemia may also be increased when hypoglycaemic agents are co-administered with certain drugs such as salicylates, sulphonamides, Chloramphenicol, coumarins, Probenecid, monoamine oxidase (MAO) inhibitors, and adrenergic blockers.
Contraindications
Repaglinide is contraindicated in patients with:
Diabetic ketoacidosis, with or without coma.
Type 1 diabetes mellitus and
Known hypersensitivity to the drug or its inactive ingredients.
Side Effects
The most common side effects of Repaglinide are hypoglycemia and related symptoms. Others include upper respiratory tract infections, diarrhea, constipation, nausea and vomiting. Hypersensitivity reactions include rashes and urticaria.
Pregnancy & Lactation
Safety in pregnant women has not been established. Repaglinide should be used during pregnancy only if it is clearly needed. It is not known whether Repaglinide is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Repaglinide, a decision should be made whether to discontinue nursing or the drug, taking into account the importance of the drug to the mother.
Precautions & Warnings
Insulin should be substituted during concurrent illness (such as myocardial infarction, coma, infection, and trauma) and during surgery. All oral blood glucose-lowering drugs are capable of producing hypoglycemia. Repaglinide should be administered with meals to lessen the risk of hypoglycemia.
Overdose Effects
Patients receiving up to 80 mg of Repaglinide developed few adverse effects other than lowering of blood glucose. Hypoglycemia did not occur when meals were given with these high doses. Severe hypoglycemic reactions with coma, seizure or other neurological impairment occur infrequently.
Storage Conditions
Do not store above 30°C. Keep away from light and out of the reach of children.
Alternative brands of Repaglinide
Other brands with the same generic name, cheapest first.